QSIGHT TRACKER ALERTS
Guidepoint Qsight has been gathering insights from our panel of over 400 facilities to keep our customers informed and ahead of the curve. The below TRACKER Alerts capture procedure-specific trends and sentiments to help you get essential information quickly.
TRACKER Alert on the Aesthetics Market – February 2023
Insights in the report include:
- Biggest challenges for the coming year
- Revenue and patient cancellations expectations
- Practice spend expectations
- Qualitative verbatim responses to provide further context into expected trends
TRACKER Alert on the CAR-T Market – December 2022
Insights in the report include:
- Currently prescribed and expected to be prescribed CAR-T therapies by brand
- Anticipated shifts in site of care
- Abecma vs. Carvykti attribute comparison
- Same-site analysis comparing responses to June 2022
TRACKER Alert on the Aesthetics Market Update: Q3 Review & Q4 Outlook – November 2022
Insights in the report include:
- Q3 2022 impact of the economic environment on aesthetic procedures
- Changes to patient procedure preferences
- Anticipated impact of the economic environment in Q4 2022
- Qualitative verbatim responses provide further context into the expected trends
TRACKER Alert on the Aesthetics Market – October 2022
Insights in the report include:
- Expectations on Daxxify usage
- Impact of Daxxify on Current Neurotoxin Product Mix
- Factors affecting Daxxify adoption
- Qualitative verbatim responses provide further context into the expected trends
TRACKER Alert on the TMVR-TTVR Market – September 2022
Insights in the report include:
- Current global TMVR-TTVR product usage and expected future usage
- Expected U.S. TMVR-TTVR product usage
- Factors affecting TMVR-TTVR utilization given Edward’s PASCAL FDA-approval
- Qualitative verbatim responses provide further context into the expected trends
TRACKER Alert on the CAR-T Market– July 2022
Insights in the report include:
- Currently prescribed CAR-T therapies by cancer type (apheresis and infusion)
- Currently infused and expected to be infused CAR-T therapies by brand
- Anticipated changes in prescribing habits
- Qualitative verbatim responses provide further context into the expected trends
TRACKER Alert on the Aesthetics Market – July 2022
Insights in the report include:
- Q2 2022 impact of the economic environment on aesthetic procedures
- Changes to patient procedure preferences
- Anticipated impact of the economic environment in Q3 2022 and Q4 202
- Qualitative verbatim responses provide further context into the expected trends
TRACKER Alert on the Mobile Cardiac Telemetry Market – March 2022
Insights in the report include:
- Non-Implantable Cardiac Monitoring device usage
- Mobile Cardiac Telemetry current and expected usage overview
- Overall MCT Market Trends, plus growth drivers and challenges to market growth
- Consumer wearables overview in relation to the MCT market, as well as anticipated usage in the clinical decision-making process
TRACKER Alert on the Liquid Biopsy Market – January 2022
Insights in the report include:
- Current usage of liquid and tissue biopsies
- Liquid biopsy market analysis by product
- Liquid biopsy tests ordered by cancer-type, primary clinical application, and reason
- Liquid biopsy test shortcomings and overall product satisfaction
- Expected shift in overall expected test share through qualitative verbatim responses
TRACKER Alert on Spinal Cord Stimulation Procedures – October 2021
Insights in the report include:
- Painful Diabetic Neuropathy (PDN) facility usage analysis
- PDN off-label usage by product
- PDN and Non-Surgical Back Pain (NSBP) patient satisfaction and outcomes
- Forward-looking PDN and NSBP expected growth rates
TRACKER Alert on the Liquid Biopsy Market – August 2021
Insights in the report include:
- Current usage of liquid and tissue biopsies
- Liquid biopsy market analysis by product
- Liquid biopsy tests ordered by cancer-type, primary clinical application, and reason
- Liquid biopsy test shortcomings and overall product satisfaction
- Forward-looking expected unit-share shifts by product
TRACKER Alert on Q3 2021 Expected Procedure Volumes – July 2021
Insights in the report include:
- Expected Q3 procedure growth rates by market, weighted by practice volume
- Estimated manufacturer unit share shifts for Q3 vs. Q2 2021
- Qualitative verbatim responses providing further context into the expected Q3 volumes
TRACKER Alert on Spinal Cord Stimulation Procedures – June 2021
Insights in the report include:
- Factors influencing future SCS procedures volumes
- Senza Omnia, Intellis DTM, Spectra Wavewriter Alpha, Nalu product attribute ratings
- Perspectives on anticipated SCS product launches
- Expected procedure growth per expanded clinical indication
TRACKER Alert on Orladeyo for HAE and Tyvaso for PH-ILD – May 2021
Insights in the report include:
- Physician ratings on all the FDA approved HAE drugs including the newly approved Orladeyo
- Anticipated switch to Orladeyo from Cinryze, Haegarda, and Takhzyro in 2021
- Estimated percentage of patients appropriate for Tyvaso
- Anticipated usage of Tyvaso by year-end 2021, 2022, and 2023
TRACKER Alert on Revance Therapeutics (RVNC) – February 2021
Insights in the report include:
- Market penetration and usage of RHA products
- Perception and anticipated use of DAXI
- Expected shifts in unit share for dermal fillers and neurotoxins through 2022
- Allergan-Evolus ITC Ruling Perspectives
TRACKER Alert on Orladeyo for HAE and Tyvaso for PH-ILD – January 2021
Insights in the report include:
- Physician ratings on all the FDA approved HAE drugs including the newly approved Orladeyo
- Anticipated switch to Orladeyo from Cinryze, Haegarda, and Takhzyro in 2021
- Estimated percentage of patients appropriate for Tyvaso
- Anticipated usage of Tyvaso by year-end 2021, 2022, and 2023
TRACKER Alert on Spinal Cord Stimulation Procedures – November 2020
Insights in the report include:
- Current and expected SCS product usage and procedure trends
- Senza Omnia vs. Intellis DTM product attributes
- Perspectives on anticipated SCS product launches
- Expected procedure growth per expanded clinical indication
TRACKER Alert on Medical Aesthetics – October 2020
Insights in the report include:
- Current RHA product usage and expected market penetration
- Awareness and perception of anticipated DAXI launch
- Expected shifts in unit share for dermal fillers and neurotoxins given Revance’s product portfolio
- Factors influencing future product usage
TRACKER Alert on TAVR and TMVR Procedures – October 2020
Insights in the report include:
- Current and expected TAVR procedures by indication and patient-risk
- TAVR and MitraClip patient backlog in September 2020
- Expected shifts in patient volume and product usage in Q4 2020
- Anticipated clinical breakthroughs in TAVR and TMVR markets
TRACKER Alert on HAE – September 2020
Insights in the report include:
- Satisfaction with current HAE treatments
- Awareness of new HAE products in development
- Likelihood of switching to new pipeline products when approved and available
- Percentage of currently treated HAE patients who would switch to pipeline products, by current treatment
TRACKER Alert on Ortho Robotic-Assist Surgery Systems – September 2020
Insights in the report include:
- Attitudes towards robotic-assisted surgeries vs. traditional surgical approaches
- Expectations for increased robotics use at practice in the future
- Likelihood of a purchasing robotics system in the future
- Impact of COVID-19 on robotics usage within the practice
TRACKER Alert on PAH Market – August 2020
Insights in the report include:
- Current landscape of PAH patients in TRACKER data by drug class and year-over-year changes in patient volumes
- Awareness of PAH pipeline treatments
- Likelihood of future use of pipeline treatments
- Awareness and perception of Remunity pump
